Knowledge, Attitude &practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
NCT06743880 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 323
Last updated 2024-12-20
Summary
* Cervical cancer is caused by persistent infection with certain strains of the human papillomavirus (HPV), which is a very common virus transmitted through sexual activity.
* HPV infections can lead to the development of precancerous lesions on the cervix, which if left untreated, can progress to invasive cervical cancer over time.
* Cervical cancer is the second most common cancer among women in Egypt, after breast cancer.
* According to the latest available data, the age-standardized incidence rate of cervical cancer in Egypt is approximately 6.3 per 100,000 women.
* However, the actual burden of cervical cancer in Egypt is likely underestimated, as many cases may go undetected or unreported, especially in rural and underserved areas.
The main objectives of this KAP study are:
1. To assess the level of knowledge about HPV and HPV vaccination among the target population.
2. To investigate the attitudes and perceptions towards HPV vaccination.
3. To identify the current practices and uptake of HPV vaccination.
4. To explore the factors influencing the knowledge, attitudes, and practices related to HPV vaccination.
Conditions
- Human Papilloma Virus (HPV) Vaccine
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 9 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2025-01-01
- Completion
- 2026-03-01
More Related Trials
-
Human Papilloma Virus (HPV) Knowledge and Attitudes and the Role of (SES) Socioeconomic Status and Ethnicity
NCT01105000 ·Status: COMPLETED
-
The Human Papilloma Virus Effect on Sexual Life
NCT03837028 ·Status: COMPLETED
-
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
NCT00481767 ·Status: COMPLETED ·Phase: PHASE3
-
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
NCT01588301 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Acceptability and Feasibility of Human Papilloma Virus Vaccine
NCT01209338 ·Status: UNKNOWN ·Phase: NA
-
Survey of Predictors of Human Papillomavirus (HPV) Vaccination Among Parents of Rural Adolescent Girls in Mysore, India
NCT01307774 ·Status: UNKNOWN
-
Human Papillomavirus Education Programs
NCT04880837 ·Status: COMPLETED ·Phase: NA
-
Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination
NCT03888599 ·Status: COMPLETED
-
Prevaccination Study of Cervical Human Papillomavirus Types in Yangtze River Delta Area, China
NCT01487681 ·Status: UNKNOWN
-
Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake
NCT03337269 ·Status: COMPLETED ·Phase: NA
-
Impact of HPV Vaccine On The Prevalence Of HPV In Norway
NCT02934724 ·Status: COMPLETED
-
Comparing Strategies for Implementing Primary HPV Screening
NCT04371887 ·Status: UNKNOWN ·Phase: NA
-
Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia
NCT05125380 ·Status: RECRUITING ·Phase: NA
-
Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China
NCT01021904 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Evaluation of Detection of High Risk HPV in Urine
NCT05210348 ·Status: UNKNOWN
-
Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women
NCT01289873 ·Status: COMPLETED
-
An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women
NCT02464358 ·Status: COMPLETED ·Phase: NA
-
Study of the Impact of a School Program Combining - Promotion of HPV Vaccination and HPV Vaccine Offer in Middle School - on Adherence to HPV Vaccination in Middle School Students
NCT04459221 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
NCT00019110 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Human Papillomavirus (HPV) Vaccine in Solid Organ Transplant Recipients
NCT00677677 ·Status: COMPLETED ·Phase: PHASE3
-
A Tailored, Health Communication Intervention for HPV Vaccine Hesitant Families
NCT04380623 ·Status: UNKNOWN ·Phase: NA
-
A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls
NCT02834637 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effectiveness of Cervical Screening in HPV Vaccinated Women
NCT02149030 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Comparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical Lesions
NCT00154583 ·Status: UNKNOWN
-
HPV Infections, Cancer of the Vulva and Therapeutical Success
NCT03082950 ·Status: COMPLETED